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Abstract
The relationship between the parental genomes in
terms of the future growth and development of their
offspring is not critical. For the majority of the
genome the tissue-specific gene expression and
epigenetic status is shared between the parents
equally, with both alleles contributing without
parental bias. For a very small number of genes the
rules change and control of expression is restricted to
a specific, parentally derived allele, a phenomenon
known as genomic imprinting. The insulin-like growth
factor 2 (Igf2/IGF2) is a robustly imprinted gene,
important for fetal growth in both mice and humans.
In utero IGF2 exhibits paternal expression, which is
controlled by several mechanisms, including the
maternally expressing untranslated H19 gene. In the
study by Soubry et al., a correlation is drawn between
the IGF2 methylation status in fetal cord blood
leucocytes, and the obesity status of the father from
whom the active IGF2 allele is derived through his
sperm. These data imply that paternal obesity affects
the normal IGF2 methylation in the sperm and this in
turn alters the expression of IGF2 in the baby.
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Background
The “parental conflict hypothesis” is the most widely
accepted explanation for genomic imprinting [1]. This
hypothesis is based on the conflicting interests of the
maternal and paternal genomes during the offspring’s
growth and development. The paternal genes are directed
towards the growth and fitness of the fetus, enhancing the
chances of his genome to be passed on to successive gen-
erations. The maternal genome attempts to limit fetal
growth in order to distribute equal resources to each
member of her litter, while ensuring her own survival dur-
ing birthing to be able to reproduce again. Studies of
imprinted genes generally support this model, with one of
the most striking examples being the mouse insulin-like
growth factor II (Igf2) [2,3] and its chelating insulin-like
growth factor II receptor (Igf2r), which show reciprocal
imprinting effects and associated growth patterns [4].
IGF2 is an important human fetal growth promoter that is
regulated by the nearby H19 gene, which is also oppositely
imprinted in humans [5,6]. For a handful of these
imprinted, haploinsufficient and fetally expressing genes,
including IGF2, their transcription is potentially more vul-
nerable. Alterations in their regulation through either
mutation or disturbed epigenetic processes may lead to
functional abnormalities and disease states.
Methylation variation and the link to functional
expression
Good examples of epigenetic syndromes are the rare
imprinted human growth disorders Beckwith-Wiedemann
syndrome (BWS) and Silver-Russell syndrome (SRS),
where IGF2 and H19 methylation are mechanistically
implicated and are considered to be functionally important
[7]. It now seems evident that disruption to epigenetic
marks, such as DNA methylation or histone modifications,
can affect the structure of chromatin and, therefore, the
binding of transcription factors and other regulatory pro-
teins [8]. DNA methylation is relatively easy to study from
stored DNA samples and generally involves making com-
parative assessment of the methylation variation at CpG
islands, promoters or differentially methylated regions
(DMRs) between control and experimental groups of sub-
jects. Importantly, there are both tissue- and age-specific
methylation profiles and for many such marks, there is a
high level of intra- and inter-individual variation that
appears to have no phenotypic consequence. Caution
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must, therefore, be employed when analyzing these data. It
is clear that more detailed and carefully controlled studies
will be necessary to gain a complete understanding of key
methylated marks and their variation relevance to develop-
ment and disease [9].
IGF2 expression in fetal samples and links to growth
There have been many studies investigating the effect of
human placental expression of IGF2 and its receptors on
fetal growth. Given the limitations of this type of study it
is not surprising that they are usually confined to samples
obtained at the time of birth. Unfortunately, many of these
studies seem to report conflicting results. For example, in
one study no correlation was reported between IGF2
expression and birth weight [10], whereas others have
shown that in small for gestational age (SGA) babies’ preg-
nancies, IGF2 expression is either increased [11], or
decreased [12], including at the protein level [13]. Never-
theless, it seems likely that IGF2 should play an important
role in dictating fetal growth, even though this effect may
not be reliably detected in term placenta.
This study and future research
In the study by Soubry et al. [14], the authors assess the
relationship between the physiological body mass index
(BMI) or obesity status of the parents with the level of
methylation seen for the IGF2 and H19 gene DMRs in the
leucocytes from cord blood of their newborns (n = 79).
They find an association between the father’s obesity sta-
tus and the loss of methylation at the DMR linked to IGF2
but not the H19 DMR. The main caveats of this study are
the small numbers and the mixture of ethnicities. In addi-
tion, it has not been shown in this study whether a small
change in methylation (in this case, 4 to 5%) at a DMR has
any truly functional significance at the phenotype level.
The authors point to their previous finding that a 5% loss
of methylation could lead to a 10% increase in serum con-
centration of IGF2 [15]. While it seems feasible that this
might have both short and longer term consequences for
health, it has not as yet been associated with an actual
change to fetal growth. The Soubry et al. [14] study, for
example, found no correlation between methylation or
parental obesity and birth weight. Nevertheless, this study
provides the first evidence that hypo-methylation of the
regulatory control region for IGF2 is influenced by
increased paternal BMI and the study makes a compelling
case for a larger analysis to be performed. It is surprising
and counter intuitive to note that a similar effect of hypo-
methylation on the IGF2 DMR is seen both for paternal
obesity and maternal preconceptual famine [16]. One
might assume that the father’s BMI was also affected by
the famine.
Conclusions
Fetal growth and development in utero is complex and
will involve multiple gene pathways, many of which will
not be haploinsufficient or driven by one parental allele.
It is important and of particular human interest to
allude to the differing roles of the parents in the devel-
opmental outcome of the future offspring. Without even
considering imprinted genes, it is obvious that the two
parents must have different physiological roles in preg-
nancy. We must consider the whole genome/epigen-
ome/metabolome in an unbiased way, involving all key
genes and networks. It is also important to critically
assess environmental players. It is tempting to over-
emphasize the role of a small number of parent-of-ori-
gin expressing genes and to speculate about the effects
of modest variation in methylation, but we must not be
too hasty to blame either parent for their offspring’s
health outcomes without being certain that these effects
are consequentially robust.
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